Evidence map›Paper›PMID 30977548›Full record

ReviewJournal of orthopaedic research : official publication of the Orthopaedic Research Society2019

Designer Stem Cells: Genome Engineering and the Next Generation of Cell-Based Therapies.

Farshid Guilak, Lara Pferdehirt, Alison K Ross, Yun-Rak Choi, KelseyH Collins, Robert J Nims, Dakota B Katz, Molly Klimak, Suzanne Tabbaa, Christine T N Pham

Abstract readReview
In one paragraph

Review in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Emerging frontiers in regenerative medicine.Science (New York, N.Y.) · 2023
    Article
  7. Chondrogenic Differentiation of Human-Induced Pluripotent Stem Cells.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  8. Review
  9. Advanced Gene Therapy Strategies for the Repair of ACL Injuries.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Emerging Gene-Editing Modalities for Osteoarthritis.International journal of molecular sciences · 2020
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Farshid GuilakDepartment of Orthopaedic Surgery, Washington University, St. Louis, Missouri.ORCID 0000-0001-7380-0330
Lara PferdehirtDepartment of Orthopaedic Surgery, Washington University, St. Louis, Missouri.
Alison K RossDepartment of Orthopaedic Surgery, Washington University, St. Louis, Missouri.
Yun-Rak ChoiDepartment of Orthopaedic Surgery, Washington University, St. Louis, Missouri.
KelseyH CollinsDepartment of Orthopaedic Surgery, Washington University, St. Louis, Missouri.
Robert J NimsDepartment of Orthopaedic Surgery, Washington University, St. Louis, Missouri.
Dakota B KatzDepartment of Orthopaedic Surgery, Washington University, St. Louis, Missouri.
Molly KlimakDepartment of Orthopaedic Surgery, Washington University, St. Louis, Missouri.
Suzanne TabbaaSymplexBio Consulting LLC, Flagstaff, Arizona.
Christine T N PhamDepartment of Medicine, Division of Rheumatology, Washington University, St. Louis, Missouri.

Funding

Thermally-Triggered Intra-articular Drug Delivery for OAP01AR050245 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2003 to 2012
$11.5M
VISCOELASTIC PROPERTIES OF NORMAL AND OA CHONDRONSR01AG015768 · NIA · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 1998 to 2022
$7.7M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Alfred Hyoungju Kim · 2018 to 2026
$7.6M
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)P30AR074992 · NIAMS · WASHINGTON UNIVERSITY · PI MATTHEW J SILVA · 2019 to 2026
$6.8M
The Role of the Osteoblast Secretome in Bone FormationP30AR057235 · NIAMS · WASHINGTON UNIVERSITY · PI SILVA, MATTHEW J · 2009 to 2018
$5.7M
OBESITY, BIOMECHANICS, AND INFLAMMATION IN OSTEOARTHRITISR01AG046927 · NIA · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 2013 to 2023
$3.2M
Mechanical and Osmotic Signaling in ChondrocytesR01AR048182 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2003 to 2013
$3.0M
Imaging, Modeling and Engineering of Diabetic TissuesT32DK108742 · NIDDK · WASHINGTON UNIVERSITY · PI NICHOLS, COLIN G · 2016 to 2020
$1.4M
Intrinsic Repair of the Knee MeniscusR01AR048852 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2007 to 2011
$1.4M
Live-Animal Micro-CT SystemS10OD010707 · OD · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2012 to 2012
$366k
Piezo channel activation and mechanotransduction in chondrocytes during traumatic injuryF32AR074240 · NIAMS · WASHINGTON UNIVERSITY · PI NIMS, ROBERT JOHN · 2018 to 2020
$196k
NIAMS NIH HHS F32 AR074240NIAMS NIH HHS P01 AR050245NIAMS NIH HHS P30 AR057235NIAMS NIH HHS P30 AR073752NIAMS NIH HHS P30 AR074992NIAMS NIH HHS R01 AR048182NIAMS NIH HHS R01 AR048852NIA NIH HHS R01 AG015768NIA NIH HHS R01 AG046927NIDDK NIH HHS T32 DK108742NIH HHS S10 OD010707
6 · The paper itself

Abstract

Stem cells provide tremendous promise for the development of new therapeutic approaches for musculoskeletal conditions. In addition to their multipotency, certain types of stem cells exhibit immunomodulatory effects that can mitigate inflammation and enhance tissue repair. However, the translation of stem cell therapies to clinical practice has proven difficult due to challenges in intradonor and interdonor variability, engraftment, variability in recipient microenvironment and patient indications, and limited therapeutic biological activity. In this regard, the success of stem cell-based therapies may benefit from cellular engineering approaches to enhance factors such as purification, homing and cell survival, trophic effects, or immunomodulatory signaling. By combining recent advances in gene editing, synthetic biology, and tissue engineering, the potential exists to create new classes of "designer" cells that have prescribed cell-surface molecules and receptors as well as synthetic gene circuits that provide for autoregulated drug delivery or enhanced tissue repair. Published by Wiley Periodicals, Inc. J Orthop Res 37:1287-1293, 2019.

Indexed as

AnimalsEpigenesis, GeneticGene EditingGenetic EngineeringHumansOrthopedicsStem Cell TransplantationTissue EngineeringCRISPR-Cas9iPSCMSCregenerative medicinesynthetic biology

Identifiers

PMID30977548
PMCPMC6546536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.